CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-09 | HERSHBERG ROBERT Director | Grant or award | +8,650 | 10,659 | ||
| 2022-06-09 | HERSHBERG ROBERT Director | Grant or award · Stock Option (Right to Buy) | +11,893 | 11,893 | ||
| 2022-06-09 | EPSTEIN ROBERT S Director | Grant or award | +8,650 | 11,331 | ||
| 2022-06-09 | EPSTEIN ROBERT S Director | Grant or award · Stock Option (Right to Buy) | +11,893 | 11,893 | ||
| 2022-06-09 | COUGHLIN TIMOTHY Director | Grant or award | +8,650 | 9,892 | ||
| 2022-06-09 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (Right to Buy) | +11,893 | 11,893 | ||
| 2022-06-09 | Agarwal Shefali Director | Grant or award | +8,650 | 10,490 | ||
| 2022-06-09 | Agarwal Shefali Director | Grant or award · Stock Option (Right to Buy) | +11,893 | 11,893 | ||
| 2022-06-09 | Redmile Group, LLC Director | Grant or award | +8,650 | 12,968,553 | ||
| 2022-06-09 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +11,893 | 11,893 | ||
| 2022-06-09 | Lee Michael Stewart Director | Grant or award | +8,650 | 11,331 | ||
| 2022-06-09 | Lee Michael Stewart Director | Grant or award · Stock Option (Right to Buy) | +11,893 | 11,893 | ||
| 2022-06-07 | Agarwal Shefali Director | Sale | −841 | $21.89 | $18K | 1,840 |
| 2022-06-03 | Agarwal Shefali Director | Sale | −0 | 2,681 | ||
| 2022-06-03 | MENDLEIN JOHN Director | Sale | −1,364 | $22.79 | $31K | 158,091 |
| 2022-06-03 | Jooss Karin Director | Sale | −1,483 | $22.82 | $34K | 1,198 |
| 2022-06-03 | HERSHBERG ROBERT Director | Sale | −672 | $22.75 | $15K | 2,009 |
| 2022-06-03 | COUGHLIN TIMOTHY Director | Sale | −1,439 | $22.81 | $33K | 57,632 |
| 2022-06-03 | Agarwal Shefali Director | Sale | −807 | $22.80 | $18K | 1,874 |
| 2022-06-01 | TAHL CINDY General Counsel and Secretary | Option exercise | +25,000 | $6.55 | $164K | 214,151 |
Page 10 of 26 · 503 trades